TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into an agreement with the University of Health Sciences Antigua (“UHSA”) to collaborate on…


Previous articleMYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics
Next articleDiamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial